Patent · US Active

Modified immunization vectors

US11345928B2 · kind B2 · utility

1Cited by
31References
21Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJul 17, 2019
Grant dateMay 31, 2022
Priority date—
Expiry dateJul 17, 2039

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The disclosure relates to recombinant vectors and methods for using the same. In certain embodiments, the recombinant vectors are immunogenic.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.